Latisse ™ is the first and only Health Canada and FDA approved eyelash enhancement product.
Toronto, Canada (PRWEB) November 10, 2010
Dr. David. A. F. Ellis, prominent Facial Plastic Surgeon, is pleased to announce that Latisse ™ will be available at his Toronto clinic, Art of Facial Surgery, on November 15th.
Latisse ™ is the first and only Health Canada and FDA approved eyelash enhancement product. Produced by Allergen (the same company who manufactures Botox), the Latisse ™ prescription is used to treat hypotrichosis, a technical term for having too few eyelashes. Allergan has the patent for the use of the active ingredient bimatoprost, which is approved by Health Canada and the FDA for cosmetic purposes. The product priced at $150 is not very expensive in comparison with other products in the same category and is known to produce results.
Latisse ™ is a non-surgical cosmetic procedure that provides its users with darker, longer, fuller, more attractive eyelashes. It is a topical formula that is applied over a period of a few months. For most people, results from this treatment are visible after about 8 weeks of use, and full results after 4 months.
Now that Latisse ™ is available at Art of Facial Surgery in Toronto, those born with sparse eyelashes can get their eyes noticed like never before, with darker, longer, fuller and thicker eyelashes.
The Toronto office of Art of Facial Surgery (http://www.artoffacialsurgery.com) focuses on Facial Cosmetic Surgery, Facelift, Rhinoplasty, Botox, Injectable Fillers and Laser Aesthetics.
For an interview, or more information, please call Yien Truong at
416-229-1050, or email at yientruong(at)artoffacialsurgery(dot)com